Control group (n = 21) | DM group (n = 24) | p-value | |
---|---|---|---|
Age; years | 61.3 ± 12.4 | 61.1 ± 10.5 | 0.943 |
Sex; Male/Female | 15/6 | 19/5 | 0.801 |
Height; cm | 165.3 ± 9.2 | 166.7 ± 7.9 | 0.592 |
Weight; kg | 67.4 ± 12.5 | 67.7 ± 14.7 | 0.939 |
BMI; kg/m2 | 24.5 ± 3.1 | 24.4 ± 4.9 | 0.919 |
Length of DM; years | NC | 10 (11) | - |
HbA1c; mg/dl | NC | 8.5 (2.7) | - |
DM type; I/II | NC | 1/23 | - |
End organ damage; 0/1/2 | NC | 18/5/1 | - |
H-M dosagea; mg | 10.1 ± 0.8 | 10.2 ± 0.8 | 0.614 |
Onset time; min | 7.8 ± 1.9 | 7.0 ± 1.3 | 0.14 |
Recovery time; min | 116.2 ± 22.9 | 119.2 ± 19.5 | 0.644 |
Sensory block level | T11 (4) | T10 (2) | 0.096 |